Loading...
XNYSOMI
Market cap1.11bUSD
Jan 08, Last price  
14.41USD
1D
4.12%
1Q
7.06%
Jan 2017
-59.17%
Name

Owens & Minor Inc

Chart & Performance

D1W1MN
XNYS:OMI chart
P/E
P/S
0.11
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
4.78%
Rev. gr., 5y
0.99%
Revenues
10.33b
+3.80%
4,525,105,0004,822,414,0005,533,736,0006,800,466,0007,243,237,0008,037,624,0008,123,608,0008,627,912,0008,908,145,0009,071,532,0009,440,182,0009,772,946,0009,723,431,0009,318,275,0009,838,708,0009,210,939,0008,480,177,0009,785,315,0009,955,475,00010,333,967,000
Net income
-41m
L
60,500,00064,420,00048,752,00072,710,00093,327,000104,658,000110,579,000115,198,000109,003,000110,882,00066,503,000103,409,000108,787,00072,793,000-437,012,000-22,584,00088,074,000221,589,00022,389,000-41,301,000
CFO
741m
+127.91%
58,654,000135,374,000-73,580,000219,840,00075,813,000175,577,000242,923,00068,141,000218,506,000140,554,000-3,761,000269,597,000186,934,00056,774,000115,589,000166,085,000339,223,000124,177,000325,006,000740,710,000
Dividend
Dec 14, 20210.002 USD/sh
Earnings
Feb 18, 2025

Profile

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.
IPO date
Mar 17, 1980
Employees
22,500
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
10,333,967
3.80%
9,955,475
1.74%
Cost of revenue
10,024,623
9,774,592
Unusual Expense (Income)
NOPBT
309,344
180,883
NOPBT Margin
2.99%
1.82%
Operating Taxes
(13,425)
(11,498)
Tax Rate
NOPAT
322,769
192,381
Net income
(41,301)
-284.47%
22,389
-89.90%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
204,082
79,336
Long-term debt
2,335,456
2,913,906
Deferred revenue
Other long-term liabilities
122,592
114,943
Net debt
2,288,054
2,907,057
Cash flow
Cash from operating activities
740,710
325,006
CAPEX
(190,870)
(166,582)
Cash from investing activities
(137,254)
(1,804,476)
Cash from financing activities
(417,330)
1,497,105
FCF
907,836
72,033
Balance
Cash
243,037
69,467
Long term investments
8,447
16,718
Excess cash
Stockholders' equity
489,981
526,710
Invested Capital
3,363,867
3,838,320
ROIC
8.96%
6.37%
ROCE
9.08%
4.64%
EV
Common stock shares outstanding
75,785
76,217
Price
19.27
-1.33%
19.53
-55.10%
Market cap
1,460,377
-1.89%
1,488,518
-54.67%
EV
3,748,431
4,395,575
EBITDA
596,721
409,550
EV/EBITDA
6.28
10.73
Interest
157,915
128,891
Interest/NOPBT
51.05%
71.26%